000 01495 a2200421 4500
005 20250515224007.0
264 0 _c20100616
008 201006s 0 0 eng d
022 _a1558-3597
024 7 _a10.1016/j.jacc.2010.01.046
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchotten, Ulrich
245 0 0 _aEnhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?
_h[electronic resource]
260 _bJournal of the American College of Cardiology
_cMay 2010
300 _a2343-5 p.
_bdigital
500 _aPublication Type: Comment; Comparative Study; Editorial
650 0 4 _aAcetanilides
_xpharmacology
650 0 4 _aAnti-Arrhythmia Agents
_xpharmacology
650 0 4 _aAtrial Fibrillation
_xdiagnosis
650 0 4 _aCells, Cultured
650 0 4 _aDrug Delivery Systems
650 0 4 _aFemale
650 0 4 _aHeart Atria
_xcytology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMyocytes, Cardiac
_xdrug effects
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aRanolazine
650 0 4 _aRisk Assessment
650 0 4 _aSampling Studies
650 0 4 _aSensitivity and Specificity
650 0 4 _aSodium Channels
_xdrug effects
700 1 _aVerheule, Sander
700 1 _aKerfant, Benoit-Gilles
700 1 _aGreiser, Maura
773 0 _tJournal of the American College of Cardiology
_gvol. 55
_gno. 21
_gp. 2343-5
856 4 0 _uhttps://doi.org/10.1016/j.jacc.2010.01.046
_zAvailable from publisher's website
999 _c19841863
_d19841863